Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

著者: Sarah J. Tabrizi, Ralf Reilmann, Raymund A.C. Roos, Alexandra Dürr, Blair R. Leavitt, Gail Owen, Rebecca Jones, Hans J. Johnson, David Craufurd, Stephen L. Hicks, Christopher Kennard, G. Bernhard Landwehrmeyer, Julie C. Stout, Beth Borowsky, Rachael I. Scahill, Chris Frost, Douglas R. Langbehn - The Lancet 2011 被引用: 540